Lei Nie

The Oncologist · 2007–2018

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 8 researchers here, as inferred from the citation graph.

Whom Lei Nie trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Sanjoy K. Sinha

Who trusts Lei Nie overall

  1. Maud Delattre
  2. Xinyu Zhang
  3. Jian Qing Shi
  4. Valentine Genon-Catalot
  5. Dalei Yu
  6. Adeline Samson
  7. Guohua Zou
  8. Hua Liang

Papers from Lei Nie's perspective

Ordered by how strongly the researchers Lei Nie trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia (Science Translational Medicine)
  2. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia (Science Translational Medicine)
  3. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (Science Translational Medicine)
  4. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T cell Therapy for Acute Lymphoblastic Leukemia (Cancer Discovery)
  5. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia (New England Journal of Medicine)
  6. Toxicities of chimeric antigen receptor T cells: recognition and management. (Blood)
  7. Current concepts in the diagnosis and management of cytokine release syndrome. (Blood)
  8. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. (Blood)
  9. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. (Journal of Clinical Oncology)
  10. Generalized Linear Models

Their papers